Patrice Wendling

2 weeks ago | medcentral.com | Patrice Wendling |Suchandrima Bhowmik |Youssef Rddad

Extended treatment with a lower dose of apixaban (Eliquis) is noninferior to the full dose at preventing recurrent venous thromboembolism (VTE) with less bleeding in patients with active cancer who have completed at least 6 months of anticoagulation therapy, results from the API-CAT trial show. Findings were presented at the American College of Cardiology Annual Scientific Session and simultaneously published in the New England Journal of Medicine.

3 weeks ago | medcentral.com | Susan Redline |Angie Drakulich |Avery Hurt |Patrice Wendling

Intensive medical treatment did not reduce the risk of major adverse cardiovascular events (MACE) at 5 years compared with usual care among women with ischemia and nonobstructive coronary artery disease in the WARRIOR trial. Results were presented at the American College of Cardiology (ACC25) annual meeting and are under review by JAMA.

3 weeks ago | medcentral.com | Angie Drakulich |Heidi Splete |Avery Hurt |Patrice Wendling

Once-daily, add-on treatment with the aldosterone synthase inhibitor lorundrostat significantly reduced blood pressure in adults with uncontrolled and treatment-resistant hypertension in a second pivotal trial, ADVANCE-HTN. Results were presented at the American College of Cardiology annual scientific session (ACC.25) this past weekend and are accepted for publication in the New England Journal of Medicine.

1 month ago | medcentral.com | Alexis Pellek |Suzanne Mooney |Patrice Wendling |Marcia Frellick

In reports published today in JAMA publications, the US Preventive Services Task Force (USPSTF) said it cannot rule for or against recommending screening for food insecurity in the primary care setting due to lack of evidence as to whether there would be more benefit than harm.

2 months ago | medcentral.com | Suchandrima Bhowmik |Patrice Wendling |Youssef Rddad |Aaron Tallent

IntroductionAs the number of Americans dying from cancer has continued to decline over the past several decades, the face of cancer is changing. Incidence rates are rising for many cancer types, shifting the cancer burden from the elderly to younger adults and from men to women, according to American Cancer Society Cancer Facts & Figures 2025.